Both Johnson and Johnson and Coca-Cola just beat earnings and both are pulling in capital fleeing tech, but only one of them ...

Johnson & Johnson is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the ...

This healthcare giant is on a serious run, but for investors arriving now, the question is whether the price of admission ...

Today, there has been unusually large put option activity in Johnson & Johnson (JNJ) following the stock's recent rise. The ...

Johnson & Johnson (NYSE: JNJ) recently released its Q1 earnings, surpassing analyst estimates on both revenue and earnings. The company posted adjusted earnings of $2.77 per share on revenue of $21.9 ...

Replacing $7,500 a month with dividends is a math problem before it is anything else. The number you need to invest depends ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price is back in rally mode. It is still early in the game, but the Q2 results ...

CHONGQING, CHINA - JULY 13: In this photo illustration, a smartphone displaying the logo of Johnson & Johnson (NYSE: JNJ), a leading American multinational corporation known for pharmaceuticals, ...

Johnson & Johnson (Symbol: JNJ) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $57.05B worth of stock held by ETFs, and above-average ''DividendRank'' statistics ...

On June 17, Johnson & Johnson (NYSE:JNJ) chief executive officer announced that the company doesn’t intend to enter the obesity drug market.